Flow Paradigm and its subsidiaries, nanoBioforms and FloCyte recently announced they are moving to a new facility in San Diego. "This move gives us greater access to companion technologies which provides more value to our clients. Work will not stop during the move, so keep the experiments coming." - Dana Buckman, CEO at Flow Paradigm, nanoBioforms & FloCyte.

Flow Paradigm is a full service flow cytometry contract research organization with services ranging from antibody characterization to assay development.